Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1728 results

Bayer to sell off animal health business for $7.6bn

Germany, US21-08-2019Sarah Morgan

Bayer has agreed to sell its animal health business to US-based Elanco Animal Health for $7.6 billion, as part of its strategic plan to focus on its core life sciences businesses.

Amneal and others pay $1.5m to settle antitrust suit over Alzheimer’s drug

US20-08-2019Sarah Morgan

Amneal and three other generic makers have agreed to pay $1.54 million to settle a class-action lawsuit, which alleged the companies engaged in an unlawful scheme to maintain their monopoly over an Alzheimer’s drug.

EMA and FDA aligned on marketing authorisations: report

EU, US19-08-2019Sarah Morgan

The US and Europe have reached the same conclusion in more than 90% of marketing authorisation decisions for new medicines, according to a report from the European Medicines Agency.

Fed Circuit majority ‘problematically’ adds new rule in Actavis suit: chief judge


The US Court of Appeals for the Federal Circuit yesterday, August 15, blocked Actavis’s attempt to market a generic version of Nalpropion Pharmaceuticals’ weight-loss drug Contrave.

Sanofi victorious at Fed Circ in prostate cancer drug dispute

15-08-2019Sarah Morgan

Sanofi secured a win at the US Court of Appeals for the Federal Circuit yesterday, August 14, after the appeals court concluded a lower court lacked authority to invalidate claims of a patent covering a prostate cancer drug.

Jazz Pharma buys clinical-stage biotech company

Ireland14-08-2019Sarah Morgan

Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million.

Sandoz to appeal against Amgen biosimilar ruling

US13-08-2019Sarah Morgan

Sandoz has confirmed that it plans to appeal against a decision that upheld the validity of two of Amgen’s patents for its arthritis treatment Enbrel, effectively blocking the launch of Sandoz’s biosimilar version.

Fed Circ affirms Eli Lilly victories over cancer drugs

US13-08-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta.

Bayer buys BlueRock to build cell therapy expertise

Germany, US09-08-2019Sarah Morgan

Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion.

FTC demands Boston Scientific divest business amid $4.2bn deal

US08-08-2019Sarah Morgan

The US Federal Trade Commission is requiring medical device maker Boston Scientific to divest business, as part of a settlement resolving antitrust charges related to its acquisition of UK-based healthcare company BTG.

Showing 1 to 10 of 1728 results